Cite
HARVARD Citation
Anand, K. et al. (2020). T-cell lymphoma secondary to checkpoint inhibitor therapy. Journal for immunotherapy of cancer. 8 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Anand, K. et al. (2020). T-cell lymphoma secondary to checkpoint inhibitor therapy. Journal for immunotherapy of cancer. 8 (1), p. . [Online].